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Background: Increasing rates of antimicrobial resistance among uropathogens led, among other efforts, to the
application of subtractive reverse vaccinology for the identification of antigens present in extraintestinal pathogenic
E. coli (ExPEC) strains but absent or variable in non-pathogenic strains, in a quest for a broadly protective Escherichia
coli vaccine. The protein coded by locus c5321 from CFT073 E. coli was identified as one of nine potential vaccine
candidates against ExPEC and was able to confer protection with an efficacy of 33% in a mouse model of sepsis.
c5321 (known also as EsiB) lacks functional annotation and structurally belongs to the Sel1-like repeat (SLR) family.
Herein, as part of the general characterization of this potential antigen, we have focused on its structural properties.
Results: We report the 1.74 Å-resolution crystal structure of c5321 from CFT073 E. coli determined by Se-Met SAD
phasing. The structure is composed of 11 SLR units in a topological organisation that highly resembles that found
in HcpC from Helicobacter pylori, with the main difference residing in how the super-helical fold is stabilised. The
stabilising effect of disulfide bridges in HcpC is replaced in c5321 by a strengthening of the inter-repeat
hydrophobic core. A metal-ion binding site, uncharacteristic of SLR proteins, is detected between SLR units 3 and 4
in the region of the inter-repeat hydrophobic core. Crystal contacts are observed between the C-terminal tail of
one molecule and the C-terminal amphipathic groove of a neighbouring one, resembling interactions between
ligand and proteins containing tetratricopeptide-like repeats.
Conclusions: The structure of antigen c5321 presents a mode of stabilization of the SLR fold different from that
observed in close homologs of known structure. The location of the metal-ion binding site and the observed crystal
contacts suggest a potential role in regulation of conformational flexibility and interaction with yet unidentified
target proteins, respectively. These findings open new perspectives in both antigen design and for the identification
of a functional role for this protective antigen.
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CFT073 Escherichia coli is an uropathogenic strain re-
sponsible for conditions like cystitis and pyelonephritis
(an ascending form reaching pelvis and kidneys), severe
cases of which may lead to sepsis [1]. Uropathogenic
E. coli (UPEC) bacteria are a subclass of ExPEC* Correspondence: xavier.daura@uab.cat
1Institute of Biotechnology and Biomedicine, Universitat Autònoma de
Barcelona, Bellaterra 08193, Spain
5Catalan Institution for Research and Advanced Studies (ICREA), Barcelona
08010, Spain
Full list of author information is available at the end of the article
© 2013 Urosev et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or(Extraintestinal Pathogenic E. coli), a group of pathogens
responsible for neonatal meningitis and septicaemia [2].
Increasing rates of antimicrobial resistance among uro-
pathogens, complicating the future treatment of such in-
fections, led to the development of vaccine preparations
based on specific virulence factors, which unfortunately
did not demonstrate long-term protection [3]. Hence, a
broader approach to vaccine design, including the identifi-
cation of non-virulence factors through methods such as
immunoproteomics and reverse vaccinology (targeting
of possible vaccine candidates starting from genomicLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vaccinology was used to identify a number of antigens
present in ExPEC but absent or variable in non-
pathogenic strains, suggesting that a broadly protective E.
coli vaccine may be possible [2]. The 52 kD protein coded
by locus c5321 from CFT073 E. coli was identified as one
of nine potential vaccine candidates against ExPEC and
was able to confer protection with an efficacy of 33% in a
sepsis mouse model [2]. Although an antibody-mediated
response is likely to be responsible for the capacity of
c5321 to induce protection in mice, the actual mechanism
of action of anti-c5321 antibodies is still unknown. Recent
data from our laboratories have suggested a role for c5321
in impairing the effector functions of human immuno-
globulins indicating that antibodies directed against c5321
may affect the ability of E. coli to evade the immune
system [4].
Sequence-based analysis performed with SMART [5]
and PFAM [6] indicates that the protein is composed of
Sel1-like repeats (SLRs, PFAM: PF08238). These repeats
share a consensus sequence that is responsible for their
helix-turn-helix (α/α) motif and are named after Cae-
norhabditis elegans sel-1 gene product [7]. Such motifs
are flexible in length, usually comprising 36–38 amino-
acid residues, with few key positions of small and large
hydrophobic residues. The crystal structure of the Heli-
cobacter pylori cysteine-rich protein B (HcpB) [8], con-
sidered as a prototype of the structural fold consisting of
SLR units, reveals the modular architecture with the α/α
motifs arrayed in tandems and resulting in a super-
helical fold. Structural domains composed of several
such motifs are thought to act as interaction scaffolds to
mediate protein-protein interactions. SLR units can be
present in tandem arrays of up to 30 motifs or in
groups dispersed throughout the protein sequence.
SLR-containing proteins are found in both prokaryotic
(more prevalent) and eukaryotic organisms, and are
thought to have been acquired by horizontal gene transfer.
Unfortunately, only few functional annotations are avail-
able for SLR proteins. There is accumulating evidence that
C. elegans Sel1 is involved in degradation of proteins from
the endoplasmic reticulum, while the yeast Hrd3 protein
is thought to act as an adaptor protein for membrane-
bound complexes and HcpA/B from H. pylori is specu-
lated to be responsible for the adaptation of this bacterium
to different hosts. It could be said that these molecular
functions of SLR proteins are related, in that they are asso-
ciated with signal transduction pathways [9].
SLR proteins share similar consensus sequence with
the much more abundant TPR (tetratricopeptide repeat)
protein family, in which TPR units are composed of 34
amino-acid residues [9,10]. The structural topology of
TPR-containing proteins was revealed by the structure
of the TPR domain of the protein phosphatase 5 (PP5)[11]. It displays a super-helical fold similar to the one
characteristic of the SLR family. However, the superpos-
ition of this TPR domain with HcpB highlights different
super-helix parameters, consequence of different packing
angles within and between the repeats. The region of
specific ligand binding, as observed in different TPR do-
mains, is located in the amphipathic groove of the
super-helix, with three tandem repeats likely being the
optimal minimal length for binding [10,12]. Similar in-
teractions most likely facilitate self-assembly into higher
order structures [10,13]. TPR domains, as mediators of
protein-protein interactions, have been implicated in a
wide variety of cellular functions, such as transcription,
cell cycle, protein translocation, protein degradation and
host defence.
Due to the non-globular, rather elongated architecture
of the repeating TPR and SLR units, where stabilization
of the fold is achieved mostly through short-range inter-
actions (along the primary sequence), the energy land-
scape of these proteins is distinct from that of globular
proteins. Inter- and intra-element interactions of such
quasi-one-dimensional structures are balanced in such a
way that small local perturbations yield large effects,
readily facilitating structural transitions that may be re-
lated to their biological function [14].
Unlike the case of TPR proteins, limited knowledge is
available for SLR proteins, including fewer available crys-
tal structures as well as functional annotations. Here, we
report the 1.74 Å-resolution crystal structure of c5321
from CFT073 E. coli determined by Se-Met SAD phas-
ing. The structure is composed of 11 SLR units, which
to our knowledge represents the bacterial protein with
the highest number of Sel1-like repeats solved up to
date. It displays similar packing angles to those found in
HcpB/C proteins from H. pylori, however with a distinct
mode of overall fold stabilisation. Furthermore, we re-
port the presence of a metal-ion binding site, generally
uncharacteristic of TPR and SLR proteins. Crystal con-
tacts between the C-terminal tail of c5321 and the
C-terminal section of the amphipathic groove of a mole-
cule belonging to the adjacent asymmetric unit are
analysed and their possible biological relevance discussed.
As part of a study of the antigenic properties of c5321, the
regions of the protein that are recognised by antibodies
have been mapped using murine monoclonal IgGs.
Results and discussion
Overall structure
The crystallographic structure of the functional unit (aa
24–490) of c5321 has been solved by SAD phasing and
refined to a resolution of 1.74 Å. According to predictions
by SignalP [15], the first 23 amino acids constitute a signal
sequence. The final model has R and Rfree values of 15.5%
and 19.2%, respectively. The model has acceptable root-
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(0.006 Å and 0.884 degrees, respectively) and none of the
residues lie in disallowed regions of the Ramachandran
plot (Table 1). One molecule is present in the asymmetric
unit of the crystal. Amino-acid numbering in the model
sequence reflects that of the functional unit (1–467 aa).
c5321 displays a super-helical fold (Figure 1), con-
taining eleven Sel1-like repeats, an N-terminal and two
C-terminal helices with probable capping function and a
(partly helical) C-terminal tail. Each repeat consists of
two helices, helix-1 and helix-2, formed predominantly
by thirteen residues, and connected predominantly by aTable 1 Data collection and refinement statistics
Data collection statisticsa
Space group P21
Type of crystal Se-Met derivative
(peak)
Se-Met derivative
(peak)
Wavelength (Å) 0.9791 0.9794
Unit cell:
a, b, c (Å) 48.94, 58.52, 88.35
α, β, γ (º) 90.00, 103.82, 90.00
Resolution (Å)b 37.91–1.74 (1.83–1.74) 58.57–2.28 (2.4–2.28)
Unique reflections 49642 22282
Rmerge (%) 7.9 (48.4) 8.0 (25.4)
Completness (%) 99.5 (99.4) 99.7 (99.6)
Multiplicity 5.2 (5.2) 7.1 (7.1)
Average I/σ (I) 12.0 (3.1) 13.9 (5.7)
Refinement statistics
Molecules/AU 1
R (%) 15.5
Rfree (%)
c 19.2
B factor (Å2) 17.1
RMS deviations:
Bond lengths (Å) 0.006
Bond angles (º) 0.884
No. of:
Protein residues 467
Water molecules 466
Hetero compounds 1 Mg2+, 2 Cl-, 29
ethylene glycol
Validation
Ramachandran plot:
Favoured (%) 98.8
Allowed (%) 1.2
Disallowed (%) 0
aData collected at the ID14-4 MAD beamline of ESRF [35].
bNumbers in parentheses refer to the highest resolution shell.
cRfree was calculated using a subset (5%) of the reflections not used in
the refinement.7-residue loop (Table 2). Individual repeats, tethered by
three-residue loops, stack on top of each other creating
an extended super-helical molecule with a continuous
hydrophobic core. This structure can also be viewed as
an overlapping array of three-helix bundles. The right-
handed super-helix is approximately 115 Å in length,
with a diameter of ~50 Å and a pitch (length of one
complete helical turn measured parallel to the helix
axes) of 60–65 Å. A complete helical turn comprises
about seven to eight SLR units. The N- and C-terminal
helices do not have a true SLR consensus sequence, but
they share structural homology. A closer inspection of
the amino-acid sequence suggests a role in ‘neutralizing’
hydrophobic surfaces on solvent exposed parts of the
first and last repeats, hence facilitating the molecule’s
solubility. To date, this is the known structure with the
highest number of SLR repeats for a bacterial protein.
Uncharacteristic of SLR and TPR proteins, a metal-ion
binding site, occupied by magnesium, was found be-
tween repeats 3 and 4 (Figure 1A). It resides in the nega-
tively charged patch of the amphiphilic concave surface
of the super-helix. Finally, the C-terminal region of the
molecule contacts the C-terminal tail of the molecule in
the adjacent asymmetric unit.
Similarities with other SLR and TPR proteins
The packing angles of repeats are similar to those ob-
served in the H. pylori cysteine-rich protein C (HcpC,
PDB id 1OUV) [16], comprised of 267 residues (follo-
wing signal-peptide cleavage) and sharing 47-53% se-
quence similarity (25-33% sequence identity) with c5321
(the highest structural homology with proteins in the
PDB). An important difference between the two proteins
resides in the inter-repeat disulfide bonds stabilizing the
super-helical packing in HcpC, not present in c5321.
Likewise, a shorter homologue (138 residues), H. pylori
cysteine rich protein B (HcpB) (PDB id 1KLX) [8], has a
39-46% sequence similarity with c5321 and its repeats
are also cross-linked by disulfide bonds. Finally, the pu-
tative Sel1-repeat protein kpn_04481 (228 residues) from
Klebsiella pneumoniae ssp. pneumoniae (PDB id 3RJV,
not published) shares 45-47% sequence similarity with
c5321. While HcpC displays a pattern of repeat inte-
ractions similar to that found in c5321, with slight varia-
tion in packing angles within and between the repeats,
kpn_04481 presents an uncommon packing angle of its
fifth repeat that allows contacts with the intra-repeat
loops belonging to the second and third repeats. Struc-
ture resolution and functional annotation of more SLR
family proteins shall lead to understanding the necessity
for this observed variety.
The first structure of a TPR-motif-containing protein
was solved in 1998 [11] and, to date, the structure with
the largest number of repeats (11.5) is that of the TPR
A B
Figure 1 Crystal structure of c5321 solved at 1.74 Å resolution. A. Side view of the super-helix, with a Sel1-like-repeat (SLR) unit circled
and the Mg2+-binding site between repeats 3 and 4 indicated in pale green. Helix-1 of the repeats is coloured in violet and helix-2 in green.
N-terminal and C-terminal (likely capping) helices, as well as the C-terminal tail are represented in grey. B. Top-down view (along the vertical axis)
from the C-terminus of the super-helix, depicting its concave (formed by the first helices of the repeats) and convex (formed by the second
helices) surfaces.
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[17]. A distinct packing angle of the TPR units, as well
as within repeats, allows a narrower super-helix in
which, unlike SLR proteins, convex-face helical con-
tacts are absent and those between concave helices
are less extensive. The significance of these differences in
packing between SLR and TPR assemblies is yet to beTable 2 Sel1-like repeat units in c5321
SLR Helix-1 region
(#residues)
Intra-repeat
loop #residues
Helix-2 region
(#residues)
Inter-repeat
loop #residues
1 16–28 (13) 7 36–48 (13) 3
2 52–64 (13) 7 72–84 (13) 3
3 88–100 (13) 7 108–120 (13) 3
4 124–136 (13) 7 144–156 (13) 3
5 160–172 (13) 7 180–192 (13) 3
6 196–208 (13) 7 216–228 (13) 3
7 232–244 (13) 7 252–264 (13) 3
8 268–280 (13) 8 289–301 (13) 3
9 305–317 (13) 3 321–336 (16) 3
10 340–352 (13) 7 360–372 (13) 3
11 376–388 (13) 7 396–408 (13) -understood, but is likely related to distinguishing tar-
get proteins.
Structural analysis of inter- and intra-SLR interactions
Even though the SLR family of proteins is known for a
low conservation of the consensus sequence of the re-
peat, c5321 reproduces this sequence particularly well
(Figure 2). Here, the definition of SLR derived from that
of TPR, as annotated in the SMART database has been
used. A repeat is composed of the more tightly packed
helices, named helix-1 and helix-2 (Figures 1, 3 and 4).
Alternatively, a repeat can be defined as constituted by
the two helices packed at a wider angle (helix-2 and
helix-1′), as suggested by Lüthy and collaborators based
on the structures of HcpB and HcpC [8,16]. The rational
for this alternative definition lies in the greater conserva-
tion of the latter repeat, reflected mainly in the constant
length of the shorter loop between these helices. Herein
we retain the SMART definition, as one could argue that
the repeat should correspond to the entity containing
the longer loop, which is an important component in de-
fining the super-helical geometry.
The structure-based sequence alignment in Figure 2
shows that the majority of the 11 repeats retain
Figure 2 Sequences of the eleven SLR repeats of c5321, aligned with the SLR consensus sequence. First two rows provide a counter for
intra-SLR position (first digit of the counter given in first row and second digit in second row). Second column corresponds to sequence number
in full-length protein of first residue in the row. Specific amino-acid residues in the consensus sequence (from the SMART database [5]) are
indicated with capital letters, while lower case letters stand for: p-polar; h-hydrophobic; t-turn like; s-small; c-charged; a-aromatic; l-leucine, valine
or isoleucine. Secondary-structure elements are outlined in the last row, with loop regions being represented by hyphens (except SLR9, where
helix2 is longer at the expense of the standard intra-repeat loop length). Residues matching specific conserved amino acids in the SLR consensus
sequence are coloured in orange, while consensus amino-acid types with a dominant representative in c5321 SLR units are shown in blue (with
the exception of W28r, which is coloured green for easy identification).
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3, 7, 8, 11, 14, 17, 21, 25, 32, 33 and 36, indicated in
orange, and conserved amino-acid types with domi-
nant representative at positions 4, 18, 24, 28, 29, 30,
31, 34 and 35, coloured in blue. Position 28, occupied
by aromatic residues in SLRs, is interestingly almostFigure 3 Close-up view of the interactions within and between SLR re
as given in Figure 2. The amino-acid code (e.g. Y11r) is given when the spe
consensus in Figure 2). Otherwise, only the position is specified (e.g. 24r). T
their side chains represented as sticks, reflect consensus areas with lack of
reduced importance in packing.exclusively represented by tryptophan throughout the
c5321 repeats.
The SLR consensus sequence highlights conserved gly-
cine residues at positions 8, 14, 17 and 36, of which the
last three facilitate turns in both intra- and inter-repeat
loops while the first one, along with conserved alaninepeats – convex face. Residue numbers reflect intra-SLR positions
cific amino acid is conserved in the position (as indicated in the
he colouring scheme is the same as in Figure 2. Residues in grey, with
dominant amino-acid representative. It does not necessarily reflect a
Figure 4 Close-up view of the interactions within and between SLR repeats – concave face. Residue numbers reflect intra-SLR positions as
given in Figure 2. The colouring scheme is the same as in Figure 2. Concave face is of less-conserved character than convex face (Figure 3).
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the helices within the repeat. In turn, alanine residues at
positions 3 and 33 favour the specific packing angle bet-
ween repeats (Figure 3).
SLR proteins, unlike their TPR analogues, have few
contacts across helix-2 units (convex-face helices). In
c5321, they are mostly facilitated by the conserved tryp-
tophan at position 28 (we shall use W28r to indicate re-
peat position), characteristic for this protein (Figure 2).
Interestingly, c5321 helix-2 units have a slight kink, not
found in HcpC, which effectively reduces the distance
between these units at the side of the inter-repeat loop
hence allowing the key positioning of W28r (Figure 3).
On the other hand, existing interactions between helix-1
units (concave-face helices) tend to be less conserved
(Figure 4). The angular geometry between repeats is
mainly dictated by an inter-repeat hydrophobic core
centred at conserved residue L7r in helix-1′ (Figure 3).
L7r is in almost all cases in close contact with W28r
in helix-2′, with residues 26r (hydrophobic or R), 29r
(F or Y), 30r (primarily R) and A33r in helix-2 and with
Y11r in the same helix-1′. Further contacts between helix-
2 and helix-1′ include hydrophobic interactions between
residues 10r and 26r, the interaction between residues 6r
(polar) and 29r and those between the conserved Y11r
and 30r, with the frequent presence of a hydrogen bond
between the respective hydroxyl and guanidinium groups.
Also, 30r (primarily R) is often hydrogen bonded via struc-
tural water to 24r (primarily Q) (not shown) (Figure 3). In
the convex face, the inter-repeat hydrophobic core isprotected from solvent by residues 26r and 30r from
helix-2, Y11r from helix-1′, V18r from the intra-repeat
loop and W28r from helix-2′.
Other conserved residue types (Figure 2) play an
important role in intra-repeat interactions, such as
hydrogen-bonded glutamine residues at positions 4 of
helix-1 and 35 of helix-2, the stacking of Y11r and
24r (primarily Q), along with the already mentioned
L7r and W28r contact (Figure 3).
Intra-repeat loops mainly consist of seven residues,
with SLR8 containing one additional residue and SLR9
four residues less. Such relatively long loops are import-
ant for sufficient inter-repeat packing at wide angles, i.e.
the length of these loops governs to a certain extent the
stability of the inter-repeat geometry by capping the
inter-repeat hydrophobic core. Loop tethering in the
conformation observed in the structure is achieved mainly
by interactions of conserved V18r with the inter-repeat
hydrophobic core (26r and Y11r). The inter-repeat loop is
shorter, three-residue long, and allows anti-parallel helical
packing as well to limit the angle of inter-repeat helices to
a certain degree (Figure 3).
Compared to its closest homologue HcpC, c5321 pos-
sesses greater sequence conservation and a different
means for SLR-fold stabilisation. The Hcp family is
unique among SLR proteins in that, in addition to the
contributions from the constituent hydrophobic inter-
repeat patch and the intra-repeat loop, fold stabilisation
is achieved by disulfide bond tethering the C-terminal
end of one repeat and the N-terminal end of the next
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similar inter-repeat angle, the disulfide-bond effect is
most likely substituted by W28r-mediated interactions.
Metal-ion binding site between SLRs 3 and 4
Electron density corresponding to a magnesium ion is
identified in the c5321 structure, with the metal-ion
-binding site located between repeats SLR3 and SLR4.
H99 in SLR3, E136 in SLR4 and its intra-repeat-loop
residue D138, along with three water molecules, cons-
titute the octahedral coordination ligands of the mag-
nesium ion (Figure 5). Sequence alignment of SLR units
does not reveal any other potential metal-ion-binding
sites, of similar composition, in the protein.
Interestingly, the hydrophobic inter-repeat core is not
as efficiently packed between repeats 3 and 4. This ap-
pears mainly due to alanine in position 10 of SLR4
(A133), occupied by larger residues in other repeats, and
the corresponding loss of the interaction with positions
12 and 26 of SLR3 (Figure 5A). CASTp, an application
for the detection of cavities in proteins [18], identifies a
pocket between SLR3 and 4 (volume of 80.8 Å3, area of
95.6 Å2) as one of the top two in the SLR regions, where
the other identified pocket is located between SLRs 8
and 9 that lacks the intra-repeat loop. In the case of
SLRs 3–4, fewer important interactions between helix-1′
and helices 1 and 2 along with somewhat weaker intra-
repeat loop tethering, in the absence of other compen-
satory mechanisms, would decrease the stability of the
inter-repeat packing. Mg2+ coordination by residues of the
intra-repeat loop, helix-1 and helix-1′ likely represents aA
Figure 5 Magnesium-ion-binding site in c5321. A. Mg2+ coordination b
loop. Alanine at repeat position 10 (A133) is indicated to highlight the lack
(σA-weighted 2Fo - Fc contoured at 2σ) at the metal-ion-binding site, inclumeans of stability/flexibility regulation in this region, for a
currently unknown purpose. The significance of the intra-
repeat-loop absence between SLRs 8 and 9, which could
lead to a certain degree of instability in this region
(due to greater solvent exposure of the hydrophobic
core), is also unknown.
As the likely origin of the magnesium ion in the c5321
structure is MgCl2 used in the crystallization conditions,
the natural metal ion for this system and its binding
specificities remain to be determined. Real-time quan-
titative PCR revealed that c5321 mRNA levels in the
uropathogenic strain CFT073 grown in Luria-Bertani
(LB) medium were higher in the presence of specific ion
chelators (including desferal and EDTA), suggesting a
scenario where ions that are ligands to the protein are
also regulators of its expression (Pastorello et al., unpub-
lished results). Unconventional iron binding, like the
triad His-Glu-Asp involved in magnesium-ion coor-
dination in the crystal structure of c5321, is found in X-
ray structures of proteins closely related to ferritin and
DNA-binding proteins from starved cells (Dps), e.g. Dps
from Mycobacterium smegmatis (PDB id 1VEQ) or anti-
gen TpF1 from Treponema pallidum (PDB id 2FJC).
Interestingly, all these species are dodecameric entities
presenting a spherical shell with a large inner cavity. The
iron ion binds inside the cavity at the interface bet-
ween two adjacent monomers. The histidine on one
side, and glutamate and aspartate on the other, are
provided by different subunits and configure the metal-
binding site (Figure 6). In all Dps-like structures, the iron
ion presents a possible tetrahedral or trigonal bipyramidB
y residues H99 of SLR3, E136 of SLR4 and D138 of the intra-repeat
of VdW contacts in the corresponding area. B. Electron density map
ding the three water molecules that complete the coordination.
A B
Figure 6 Similarities between the Mg-ion binding site in c5321 and Fe-ion binding site in Dps proteins. A. The Fe-ion binding site
involving the triad His-Glu-Asp found in X-ray structures of Dps proteins (PDB ID 2FJC). B. Octahedral Mg-ion coordination observed in c5321
(water molecules not indicated).
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ation might not be observed due to low resolution (e.g.
3.98-2.5 Å for the indicated structures). It cannot be ex-
cluded that the coordination of the metal-ion in c5321
could be of such lower order in a potentially native iron-
bound structure.
Metal-ion binding, as evident from the PDB reposi-
tory, is not common in SLR and TPR-containing pro-
teins. However, an example where metal-ion binding
might be partly responsible for dynamics and ligand-
binding regulation is that of human Pex5p receptor. Sr2+
binding (physiological equivalent unknown) in the
protein's TPR domain hinge region, even though in a co-
ordination not resembling the case of c5321, leads to
near rigid-body movement of its two halves (lobes) and
less overall conformational flexibility of the domain [19].
Metal ions play a role in many important functions in
proteins, including stability, conformational changes,
folding and assembly. One can speculate that for c5321
the stabilisation of the SLR 3–4 region could repre-
sent a means of regulation of overall conformational
flexibility, and in turn affect ligand (protein/peptide)
binding (suspected to be in one of the major grooves,
as discussed in the next section). Clearly, further in-
vestigation of metal-ion binding, its specificity and
functional role will be required in order to assess these
hypotheses.
Crystal contacts between the C-terminal super-helical
groove of one molecule and the C-terminal tail of the
molecule belonging to the adjacent asymmetric unit
In the crystal packing the concave surface of the super-
helix in the region of repeats 8, 9 and 10 of one moleculeinteracts with the C-terminal tail of a symmetry-related
molecule (Figure 7A). Interestingly, similar C-terminal tail
interactions have already been observed in other SLR pro-
teins, such as HcpC (Figure 8).
Interactions are predominantly of polar character ac-
companied by van der Waals contacts. N345, belonging
to repeat 10, participates in bidentate hydrogen-bonding
interactions with the backbone carbonyl oxygen and ni-
trogen atoms of the C-terminal tail's Q459. N310 of re-
peat 9 is near the C-terminal tail's A461 and could be
engaged in similar interactions with its backbone atoms,
upon rotameric change (Figure 7B). These interactions
can be categorised as anchoring, non-specific for peptide
binding in such type of groove. Specificity might be
governed by non-polar interactions of the tail peptide
with the inter-repeat core and polar interactions with
the solvent exposed repeat area. Thus, residues respon-
sible for shape complementarity comprise A458 and
A461 of the C-terminal tail in van der Waals contact
with A313 and A341, A309, T306 of the second mo-
lecule, respectively. Polar interactions involve S460 hy-
drogen bonding to R317 in SLR9 and K280 in SLR8,
while D304 and T306 in SLR9 take part in charge-
charge and hydrogen-bond interactions with K463 in the
C-terminal tail, stacking against Y272 of SLR8. Addi-
tional stacking interactions are observed between F414
belonging to one of the C-terminal helices and K455 at
the C-terminal end (Figure 7B). The last three residues
of the C-terminus, for which lower electron density is
observed, do not really contribute to the interactions
within this concave pocket.
Some similarity is shared with the mode of target-
protein/peptide binding of TPR proteins, such as receptor
A B
Figure 7 Crystal contacts: binding of the C-terminal tail of c5321 to the C-terminal concave groove of a neighbour molecule.
A. Relative orientation of the two molecules, with SLRs 7–11 alternating in purple and light blue (the rest of the molecule is represented in grey).
B. Close-up view of the interactions (see main text).
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protein-Hop (Figure 8), FKBP52 and PP5. In these,
TPR tandems recognise the C-terminal EEVD signal
sequence of the target protein/peptide by a “carboxylate
clamp” (group of conserved positively charged residues)A B
Figure 8 Similarities between crystal contacts observed in c5321 and
target (PDB ID 1ELW). A. Structural superposition highlights similar mode
and the extended peptide conformation of the C-terminus (molecule 2). B
conserved asparagine residue (molecule 1, N310 in c5321) and the main ch
asparagine residue in c5321 (N345) is also involved in interactions with the[10,20-22] and likely also utilizing bidentate hydrogen-
bonding interactions between conserved asparagine resi-
dues lining the super-helical groove and target peptide
backbone atoms [17]. Figure 8 highlights this type of
hydrogen bonding, involving a conserved asparaginein HcpC and interactions of Hop with the C-terminus of its Hsp70
of interaction involving concave region of the super-helix (molecule 1)
. Close-up of the hydrogen bonding interactions between the
ain of the C-terminus peptide (molecule 2). Note that the additional
main chain.
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In most cases, the binding pocket establishing pri-
mary interactions through the target’s C-terminal tail
is composed of three TPR repeats, in line with three tan-
dem TPR domains being the most populated, suggesting
that these represent the minimal functional binding unit.
Secondary interactions are often important for estab-
lishing specificity and are thought to lie outside of this pri-
mary region, as shown for Hop [21,23]. Cortajarena et al.
also emphasised the importance of both short-range inter-
actions and long-range electrostatics as determinants of
specificity [24].
On the other hand, there are examples of self asso-
ciation for TPR proteins, such as dimerisation of the
Sgt1 plant protein [25] or oligomerisation of the MamA
bacterial protein (demonstrated in vivo), that involve
their terminal helices binding in the super-helical groove
regions [26]. For a number of TPR-containing proteins it
has been shown that self-association can serve to regu-
late their biological function. SE-HPLC analysis of c5321
shows that aggregates/oligomers are present in very little
amount (less than 5%, data not shown), although an
exhaustive study of c5321 oligomerisation has not been
performed.
The potential biological significance of the observed
crystal contact in c5321 is revealed by comparison with
the known TPR ligand-binding examples. Indeed, they
share common features like binding in the concave area
of the super-helix with similar peptide-backbone ancho-
ring mode and three-tandem SLR domains as binding
pocket. Correlation between the crystal contacts ob-
served in the TPR protein Cyp40 and its interactions
with the natural ligand (Hsp90) in solution [27] further
suggests the possibility of a similar scenario in the c5321
case, with yet unidentified target protein/peptide (or
self-association).
Epitope mapping
Mapping of c5321 epitopes for murine monoclonal anti-
bodies was performed as part of the general characte-
rization of this protein as a potential vaccine candidate,
alongside presenting an opportunity to further investi-
gate binding regions in c5321. Proteolytic digestion of
the antigen following its incubation with monoclonal
antibodies (see Methods) did not result in identification
of any epitope-containing peptides. However, epitope-
containing peptides were captured from partial digestion
of c5321 (performed prior to incubation with monoclonal
antibodies) with GluC (IgGs 17A7-C2 and 14E7/D10) or
LysC (IgG 16H8/G6) (Figure 9).
The sequences of the epitope-containing peptides
map to helix-1 of SLR1 for mAb16H8/G6, helix-1 of
SLR10 for mAb17A7-C2 and helix-2 of SLR3 and
helix-1 of SLR4 for mAb14E7/D10 (Figure 9D). Failure toimmunocapture the products of LysC or trypsin cleavage
(at the C-terminal side of arginine or lysine residues) by
mAb17A7-C2 and mAb14E7/D10 further narrows down
the important epitope components to the intra-repeat
loop of SLR10 (containing three lysines) for mAb17A7-C2
and to the outer helix-2 of SLR3 (containing one lysine
and two arginines) for mAb14E7/D10, respectively. These
are in agreement with no steric hindrance to the access
and binding of the antibody to these convex areas of the
super-helix, and partly overlap with regions that are in-
volved in Mg2+ binding (between SLRs 3 and 4) or belong
to the C-terminal-tail binding groove (SLRs 8, 9 and 10).
How relevant this observation is with respect to the previ-
ously discussed roles of these regions remains to be fur-
ther investigated.
Conclusions
We have solved the structure of c5321 from uro-
pathogenic Escherichia coli to 1.74 Å resolution. This
antigen displays a super-helical Sel1-like repeat fold with
eleven SLR units and a remarkably preserved consensus
repeat sequence. It shares high structural similarity with
its closest homologue of known three-dimensional struc-
ture, HcpC from Helicobacter pylori, albeit with differ-
ences in how the SLR-fold is stabilized. While disulfide
bridges in HcpC lock the characteristic inter-repeat
geometry, in c5321 a conserved tryptophan residue at
repeat position 28 appears to contribute fundamentally
in maintaining the same geometry by strengthening the
inter-repeat hydrophobic core. Metal ion binding, gene-
rally uncharacteristic of SLR proteins, is observed be-
tween SLR units 3 and 4, suggesting a regulatory role in
conformational flexibility. Furthermore, crystal contacts
observed between molecules belonging to neighbour
asymmetric units share similarity to contacts characteris-
tic for TPR-protein interactions with their physiological
targets, suggesting a potential physiological interaction
mode of c5321 with yet unidentified targets. The structure
of c5321 is a first step for its functional characterisation
and opens the door to the possibility of redesigning this
antigen for vaccine-development purposes.
Methods
Cloning, expression and purification of c5321
c5321 gene, without the predicted signal sequence, was
amplified by PCR from the CFT073 genomic DNA
template, cloned in pET-21b vector (Novagen) and
transformed in DH5α-T1R chemically competent cells
for propagation. BL21(DE3) chemically competent cells
were used for His-tagged protein expression (6xHis at
the C-terminus). Purification of the recombinant pro-
tein was performed from the bacterial soluble fraction
using nickel-affinity chromatography as already described
[28,29]. Cleavage of the His-tag was not performed.
Figure 9 Epitope-mapping results. A. MS spectra of the proteolytic-digestion products of c5321 with GluC (upper spectrum) and the peptide
immunocaptured with mAb14E7/D10 (111-SVKWFRLAAEQGRDSGQQSMGDAYFE-136, lower spectrum). B. MS spectra of the proteolytic-digestion
products of c5321 with LysC (upper spectrum) and the peptide immunocaptured with mAb16H8/G6 (18-AQLELGYRYFQGNETTK-34, lower
spectrum). C. MS spectra of the proteolytic-digestion products of c5321 with GluC (upper spectrum) and the peptide immunocaptured with
mAb17A7-C2 (340-KAAQFNLGNALLQG-KGVKKDE-360, lower panel). D. Identified epitope-containing regions mapped onto the c5321 structure.
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c5321
The plasmid DNA containing the c5321 gene down-
stream of the T7 promoter was transformed into B834
DE3 cells and the protein was expressed during 8 h at
25°C using the Overnight Express Autoinduction System
2 medium (Novagen) supplemented with 100 nM vita-
min B12, 0.125 mg/ml selenomethionine and 50 μg/ml
ampicillin. The cells were harvested by centrifugation at
5000 g for 30 min.
The cell pellet was suspended in lysis buffer (50 mM
Na phosphate pH 7.5, 150 mM NaCl, 10 mM imidazole)
and the cells were lysed by sonication. The insoluble
fraction was removed by centrifugation (14000 g, 15 min)
and the cleared lysate was applied onto a Ni-NTA sepha-
rose column (Qiagen), equilibrated with the lysis buffer.
The column was washed with 10 volumes of wash buffer
(50 mM Na phosphate pH 7.5, 150 mM NaCl, 20 mM
imidazole) and the protein was eluted with a gradient of
increasing imidazole concentration (50 mM Na phosphate
pH 7.5, 150 mM NaCl, 100 mM-300 mM imidazole). The
protein-rich fractions were pooled and dialyzed 3 timesagainst 100 volumes of 50 mM Na phosphate pH 7.5,
150 mM NaCl buffer. The protein sample was concen-
trated to 10 mg/ml using a 3 kD cut-off Amicon Ultra
concentrator (Millipore). His-tag cleavage was not per-
formed. The yield of the labelled c5321 was estimated
to be about 20 mg of protein per litre of bacterial cell
culture.
Crystallisation and data collection
The protein was buffer exchanged with 5 mM Tris–HCl
pH 8.0, 1 mM β-mercaptoethanol. Crystals were grown at
18°C using the hanging drop vapour diffusion method.
The protein solution, at ~10 mg/ml concentration, was
combined in a 1:1 ratio (v/v) with a well solution con-
sisting of 20% PEG3350, 100 mM Tris–HCl pH 8.5, and
200 mM MgCl2. Prior to X-ray diffraction analysis, crys-
tals were transferred to a cryo-protectant solution (20%
ethylene glycol, 20% PEG3350, 100 mM Tris–HCl pH 8.5,
and 200 mM MgCl2) and flash cooled in liquid nitrogen.
Diffraction data were collected at 100 K at the beam-line
ID14-4, ESRF, Grenoble. These data were indexed, inte-
grated and scaled using MOSFLM and SCALA.
Urosev et al. BMC Structural Biology 2013, 13:19 Page 12 of 14
http://www.biomedcentral.com/1472-6807/13/19Structure solution and refinement
The structure was solved by the Se-Met SAD method,
using crystals that contained one molecule in the asym-
metric unit. Se-Met SAD data at 2.28 Å resolution were
collected to a satisfactory redundancy of 7.1 and rela-
tively good signal/noise ratio of 13.9. Se atoms were lo-
cated using Autosol, PHENIX [30] and initial phases
were calculated from their positions. Model building was
performed with the Autobuild module of PHENIX as
well as Buccaneer [31], combined with manual recon-
struction. Subsequent refinement was carried out with
Phenix/Coot using a Se-Met SAD 1.74-Å resolution
dataset and yielded an R factor of 15.5% and an Rfree of
19.2%. Mg2+ was identified as the most likely representa-
tive for the electron density peak in proximity of repeats
3 and 4. 2 Cl-, 29 ethylene glycol and 466 water mole-
cules were included in the final model. The quality of
the final model was assessed with PROCHECK [32].
None of the residues lie in the disallowed region of
the Ramachandran plot. The model was analysed using
Pymol, which was used for figure preparation as well.
Crystallographic statistics are shown in Table 1.
Production of monoclonal antibodies against c5321
The purified recombinant c5321 was used to immunize
CD1 mice. The first dose was a 50-μg injection, whereas
the second and third doses at days 14 and 21 were of
25 μg. At day 28, anti-c5321 titres were measured in
mice sera using ELISA plates coated with the recom-
binant c5321. A fourth dose was then administered, and
3 days later mice spleen cells were fused with myeloma
cells (NS0). After 2 weeks of incubation in hypoxanthine-
aminopterinthymidine selective medium, the hybridoma
supernatants were screened for antibody-binding activity
by ELISA. Hybridomas secreting anti-c5321 antibodies,
selected by Western Blot to determine their capacity to
recognize the antigen in bacterial extracts, were cloned by
limiting dilution and then expanded and frozen for subse-
quent purification of mAbs. The mAb subclasses were de-
termined using a mouse mAb isotyping kit (Roche). The
mAbs were purified from culture supernatant by Protein
G affinity columns (GE Healthcare), and after exhaustive
dialysis in PBS buffer, the concentration of the purified
mAb was determined by spectrophotometric reading
at 280 nm.
Epitope mapping of monoclonal antibodies
The epitope-mapping protocols are based on the ap-
proach described by [33], which we adapted to the two
different protocols used here [34]:
1) Immunocapturing of peptides from antigen partial
digestion. Peptide mixtures were obtained by digestion
of c5321 with trypsin, LysC and GluC (separately) in50 mM ammonium bicarbonate buffer in a ratio
of 10:1 at 37°C for 3 h. To capture the epitope-
containing peptide, a 25-μl suspension of Dyanbeads
Pan Mouse IgG (uniform, super-paramagnetic
polystyrene beads of 4.5 μm diameter coated with
monoclonal human anti-mouse IgG antibodies) was
used. The beads were washed twice with PBS using a
magnet and re-suspended in the initial volume. 1 μg
of the probe (murine) mAb was added and incubated
for 30 min at room temperature, the beads were then
washed twice with PBS to remove mAb excess. 0.5 μl
of Protease Inhibitor Mix (GE Healthcare) was added
before the peptide mixture to avoid potential
degradation of the antibodies. The sample was
incubated for 30 min at room temperature with gentle
mixing. After incubation, the beads were washed
three times with 1 ml PBS, and the bound peptide was
then eluted with 50 μl of 0.2% TFA. The elute fraction
was concentrated and washed with C18 ZipTips
(Millipore) and eluted in 3 μl of 50% ACN and 0.1%
TFA. For MALDI-MS analysis, 1 μl of sample was
mixed with the same volume of a solution of alpha-
cyano-4-hydroxy-transcinnamic acid matrix
(0.3 mg/ml in H2O:ACN:TFA at 6:3:1), spotted onto
the MALDI target plate and air-dried at room
temperature. MALDI-mass spectra were recorded in
the positive ion mode on an UltrafleXtreme MALDI
TOF/TOF instrument (Bruker Daltonics). Ion
acceleration was set to 25 kV. All mass spectra were
externally calibrated using a standard peptide mixture.
For MS/MS analysis, the MASCOT search engine
(Matrix Science. London, UK) was used with the
following parameters: one missed cleavage permission,
20-ppm measurement for MS and 0.3 Da for MS/MS
tolerance. Positive identification were accepted with
p < 0.05. In the searches, modification of methionine
to methionine sulfoxide was allowed.
2) Partial digestion of immunocaptured antigens. To
capture conformational epitopes, the order of the
steps in the previous protocol was inverted. The intact
protein (20 μg) was added to the beads, allowing it to
bind to the immobilised mAb. The protease was then
added to the sample in a ratio 50:1, and incubated at
37°C for 3 h. After proteolysis, the beads were washed
ten times with 1 ml PBS, and the bound peptide was
then eluted as previously described. To avoid the
analysis of proteolysed antibody fragments within the
elute fraction, c5321 was substituted by PBS in
negative controls.
Availability of supporting data
The coordinates and merged structure factors for c5321
have been deposited in the Protein Data Bank repository
under accession code 4BWR [DOI:10.2210/pdb4bwr/pdb].
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